- CA$14.28m
- CA$4.52m
- 42
- 14
- 57
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 7 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30.6 | 89.2 | 2.74 | 1.04 | 2.62 |
Operating Profit | -30.6 | -89.2 | -2.74 | -1.04 | -2.62 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -26.3 | -87.9 | 9.39 | -0.74 | -3.24 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.1 | -82.4 | 9.39 | -0.762 | -3.22 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -25.3 | -59.6 | 8.48 | -0.725 | -3.19 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.3 | -59.6 | 8.48 | -0.725 | -3.19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.141 | 0.978 | 0.19 | -0.015 | -0.064 |
Dividends per Share | |||||
Special Dividends per Share |